Clinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis

BACKGROUND: Increasing age predisposes patients with atrial fibrillation to both thromboembolic and bleeding events; however, data on outcomes of very elderly patients (aged ≥85 years) receiving appropriate antithrombotic therapy are still limited. METHODS AND RESULTS: The J‐ELD AF (Multicenter Pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Masato, Inoue, Koichi, Tanaka, Nobuaki, Sakata, Yasushi, Akao, Masaharu, Yamashita, Takeshi, Suzuki, Shinya, Okumura, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475673/
https://www.ncbi.nlm.nih.gov/pubmed/34323123
http://dx.doi.org/10.1161/JAHA.121.021224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475673/
https://www.ncbi.nlm.nih.gov/pubmed/34323123
http://dx.doi.org/10.1161/JAHA.121.021224

Ejemplares similares